Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ARS Pharmaceuticals, Inc. (SPRY)
USD7.22
-0.39 (-5.10%)
US NASDAQ Healthcare Biotechnology
Address
3525 Del Mar Heights Road 92130
San Diego, CA, US
San Diego, CA, US
CEO
Richard E. Lowenthal
Website
ars-pharma.com
IPO
2020-12-04
CIK 1671858 ISIN US82835W1080
Also trades on
NASDAQ Global Market · SBTX (USD)
NASDAQ Global Market · SPRY (USD)
Description
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
News Sentiment (7d)
6 articles
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PRNewsWire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY Globe News Wire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY GlobeNewsWire
- Can ARS Pharma's New CEO Unlock Neffy's Potential? Benzinga
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD7.22
-0.39 (-5.10%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.83
Float Shares
62.62M
Free Float %
63.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.49% | -15.53% | -9.23% | -20.84% | +1.43% | -36.27% | -47.93% | -10.43% | -73.94% | -70.30% | -70.30% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Hold
Price Targets & DCF
Current price
7.22
Low
25.00
+246.2%
Consensus
25.50
+253.1%
Median
25.50
+253.1%
High
26.00
+260.0%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
25.50
+253.1%
|
| Last Year | 4 |
28.25
+291.2%
|
| All Time | 9 |
23.89
+230.8%
|
Quality scores
Altman Z-Score
-0.89
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-5.5% Q1'26: +184.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-2,327.9% Q1'26: -74.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-238.4% Q1'26: -198.2% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-212.9% Q1'26: -265.2% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +565.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-3.7% ★ Q1'26: +1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.54× Q1'26: -0.40× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.32M
est: 1.27M (+3.8%)
|
30.0K
est: 500.0K (-94.0%)
|
89.15M
est: 8.48M (+951.3%)
|
84.28M
est: 81.73M (+3.1%)
|
149.16M
136.94M – 162.56M
+82.5% YoY
|
274.26M
245.58M – 292.47M
+83.9% YoY
|
452.99M
447.82M – 458.16M
+65.2% YoY
|
610.57M
536.11M – 668.56M
+34.8% YoY
|
677.00M
594.44M – 741.31M
+10.9% YoY
|
| EBITDA |
-35.20M
est: -776.1K (-4,434.9%)
|
-67.45M
est: -403.4K (-16,620.9%)
|
-3.00M
est: -6.84M (+56.1%)
|
-178.08M
est: -65.94M (-170.1%)
|
-120.33M
-131.14M – -110.48M
-82.5% YoY
|
-221.26M
-235.95M – -198.12M
-83.9% YoY
|
-365.44M
-369.62M – -361.27M
-65.2% YoY
|
-492.57M
-539.36M – -432.50M
-34.8% YoY
|
-546.16M
-598.04M – -479.56M
-10.9% YoY
|
| EBIT |
-35.52M
est: -776.4K (-4,474.2%)
|
-67.52M
est: -403.5K (-16,635.3%)
|
-3.08M
est: -6.84M (+54.9%)
|
-179.45M
est: -65.95M (-172.1%)
|
-120.36M
-131.17M – -110.50M
-82.5% YoY
|
-221.30M
-236.00M – -198.17M
-83.9% YoY
|
-365.52M
-369.70M – -361.35M
-65.2% YoY
|
-492.68M
-539.47M – -432.59M
-34.8% YoY
|
-546.28M
-598.17M – -479.66M
-10.9% YoY
|
| Net Income |
-34.68M
est: -102.18M (+66.1%)
|
-54.37M
est: -44.84M (-21.2%)
|
8.00M
est: -48.02M (+116.7%)
|
-171.30M
est: -166.46M (-2.9%)
|
-176.22M
-202.99M – -124.11M
-5.9% YoY
|
-93.63M
-111.87M – -39.16M
+46.9% YoY
|
16.28M
-84.31M – 84.31M
+117.4% YoY
|
97.58M
82.11M – 109.63M
+499.5% YoY
|
122.22M
102.85M – 137.31M
+25.3% YoY
|
| SGA |
18.66M
est: 403.65M (-95.4%)
|
47.28M
est: 159.39M (-70.3%)
|
—
est: 2.70B (-100.0%)
|
230.12M
est: 26.05B (-99.1%)
|
47.55B
43.65B – 51.82B
+82.5% YoY
|
87.43B
78.29B – 93.23B
+83.9% YoY
|
144.40B
142.75B – 146.05B
+65.2% YoY
|
194.64B
170.90B – 213.12B
+34.8% YoY
|
215.81B
189.49B – 236.31B
+10.9% YoY
|
| EPS |
-0.87
est: -0.94 (+7.5%)
|
-0.57
est: -0.47 (-22.4%)
|
0.08
est: -0.66 (+112.5%)
|
-1.74
est: -1.72 (-1.3%)
|
-1.72
-2.06 – -1.26
+0.0% YoY
|
-0.91
-1.14 – -0.40
+47.1% YoY
|
0.14
-0.86 – 0.86
+115.4% YoY
|
0.99
0.83 – 1.11
+609.9% YoY
|
1.24
1.04 – 1.39
+25.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-175.22M
OE per share TTM
-1.77
Owner's Yield
-23.75%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
5.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
128
Total invested
289.19M
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter Kolchinsky | 6.76M | 7.07% | — | 6.76M | — | 10.00 | HC, IN | or Place of Organization. United States | 2023-08-31 | ↗ |
| 2 | RA Capital Management, L.P. | 6.76M | 7.07% | — | 6.76M | — | 10.00 | IA, PN | Delaware | 2023-08-31 | ↗ |
| 3 | Rajeev Shah | 6.76M | 7.07% | — | 6.76M | — | 10.00 | HC, IN | States | 2023-08-31 | ↗ |
| 4 | RA Capital Healthcare Fund, L.P. | 5.86M | 6.13% | — | 5.86M | — | 10.00 | HC, IN | States | 2023-08-31 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
128
-67 vs prev Q
New positions
24
Closed positions
88
Increased
62
Reduced
35
Put/Call ratio
0.00
Calls held
29.7K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 10.86M +— (+0.0%) | 126.53M +17.4M (+15.9%) | 10.99% -0.050 pp | 1.30% -0.049 pp | USD5.83 +99.8% | 13 qtrs — |
| 2 | ORBIMED ADVISORS LLC | 8.29M +— (+0.0%) | 96.56M +13.3M (+15.9%) | 8.39% -0.038 pp | 1.98% +0.016 pp | USD44.04 -73.5% | 21 qtrs — |
| 3 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7.50M +— (+0.0%) | 87.42M +12.0M (+15.9%) | 7.59% -0.034 pp | 1.12% -0.035 pp | USD8.53 +36.6% | 13 qtrs — |
| 4 | RUBRIC CAPITAL MANAGEMENT LP | 6.20M +1.7M (+37.8%) | 72.23M +27.0M (+59.7%) | 6.27% +1.700 pp | 0.86% +0.354 pp | USD11.23 +3.7% | 4 qtrs — |
| 5 | BLACKROCK, INC. | 5.09M +254.0K (+5.3%) | 59.24M +10.7M (+22.0%) | 5.15% +0.235 pp | 0.00% +0.000 pp | USD13.83 -15.8% | 6 qtrs — |
| 6 | SR ONE CAPITAL MANAGEMENT, LP | 4.01M +— (+0.0%) | 46.75M +6.4M (+15.9%) | 4.06% -0.018 pp | 6.62% +0.785 pp | USD8.02 +45.3% | 13 qtrs — |
| 7 | ABRDN PLC | 3.56M +459.0K (+14.8%) | 41.43M +10.3M (+33.1%) | 3.60% +0.450 pp | 0.06% +0.015 pp | USD12.01 -3.0% | 4 qtrs — |
| 8 | VANGUARD GROUP INC | 3.51M +8.9K (+0.3%) | 40.88M +5.7M (+16.2%) | 3.55% -0.007 pp | 0.00% +0.000 pp | USD13.09 -11.0% | 21 qtrs — |
| 9 | STATE STREET CORP | 3.22M +328.3K (+11.3%) | 37.55M +8.5M (+29.1%) | 3.26% +0.319 pp | 0.00% +0.000 pp | USD10.50 +11.0% | 20 qtrs — |
| 10 | MILLENNIUM MANAGEMENT LLC | 3.17M +3.2M (+100.0%) | 36.91M +36.9M (+100.0%) | 3.21% +3.207 pp | 0.02% +0.016 pp | USD11.65 +0.0% | 6 qtrs — |
| 11 | FRANKLIN RESOURCES INC | 2.54M +145.1K (+6.1%) | 29.63M +5.5M (+22.9%) | 2.57% +0.136 pp | 0.01% +0.001 pp | USD5.70 +104.4% | 10 qtrs — |
| 12 | UBS GROUP AG | 2.21M +1.6M (+235.0%) | 25.76M +19.1M (+288.4%) | 2.24% +1.567 pp | 0.00% +0.003 pp | USD12.00 -2.9% | 9 qtrs — |
| 13 | TYRO CAPITAL MANAGEMENT LLC | 1.99M +2.0M (+100.0%) | 23.24M +23.2M (+100.0%) | 2.02% +2.019 pp | 4.16% +4.159 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 14 | CITADEL ADVISORS LLC | 1.95M +368.4K (+23.2%) | 22.77M +6.8M (+42.8%) | 1.98% +0.366 pp | 0.00% +0.001 pp | USD14.52 -19.8% | 21 qtrs — |
| 15 | CASDIN CAPITAL, LLC | 1.60M +— (+0.0%) | 18.64M +2.6M (+15.9%) | 1.62% -0.007 pp | 1.16% -0.183 pp | USD10.05 +15.9% | 2 qtrs — |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.55M +47.3K (+3.1%) | 18.09M +3.0M (+19.6%) | 1.57% +0.041 pp | 0.00% +0.000 pp | USD10.80 +7.9% | 21 qtrs — |
| 17 | SOUTHPOINT CAPITAL ADVISORS LP | 1.50M +— (+0.0%) | 17.48M +2.4M (+15.9%) | 1.52% -0.007 pp | 0.41% +0.011 pp | USD17.45 -33.2% | 3 qtrs — |
| 18 | JANNEY MONTGOMERY SCOTT LLC | 1.29M +74.8K (+6.2%) | 15.00M +2.8M (+23.1%) | 1.30% +0.070 pp | 0.03% +0.006 pp | USD11.86 -1.8% | 21 qtrs — |
| 19 | BAMCO INC /NY/ | 1.27M +— (+0.0%) | 14.78M +2.0M (+15.9%) | 1.28% -0.006 pp | 0.04% +0.006 pp | USD10.28 +13.3% | 3 qtrs — |
| 20 | GOLDMAN SACHS GROUP INC | 812.0K -513.7K (-38.7%) | 9.46M -3.9M (-29.0%) | 0.82% -0.526 pp | 0.00% -0.001 pp | USD13.71 -15.0% | 18 qtrs — |
| 21 | FIL LTD | 810.1K +810.1K (+100.0%) | 9.44M +9.4M (+100.0%) | 0.82% +0.820 pp | 0.01% +0.007 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 22 | LEVIN CAPITAL STRATEGIES, L.P. | 747.5K -16.8K (-2.2%) | 8.71M +1.0M (+13.4%) | 0.76% -0.021 pp | 0.75% +0.057 pp | USD10.86 +7.3% | 13 qtrs — |
| 23 | NEXTECH INVEST, LTD. | 660.7K +— (+0.0%) | 7.70M +1.1M (+15.9%) | 0.67% -0.003 pp | 0.74% -0.267 pp | USD12.58 -7.4% | 4 qtrs — |
| 24 | BANK OF MONTREAL /CAN/ | 643.4K +643.4K (+100.0%) | 7.50M +7.5M (+100.0%) | 0.65% +0.651 pp | 0.00% +0.003 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 25 | CENTERBOOK PARTNERS LP | 568.4K +56.0K (+10.9%) | 6.62M +1.5M (+28.6%) | 0.58% +0.054 pp | 0.32% +0.069 pp | USD10.21 +14.1% | 2 qtrs — |
| 26 | RAYMOND JAMES FINANCIAL INC | 566.1K -190.3K (-25.2%) | 6.59M -1.0M (-13.2%) | 0.57% -0.196 pp | 0.00% 0.000 pp | USD10.71 +8.8% | 5 qtrs — |
| 27 | GENERAL AMERICAN INVESTORS CO INC | 560.0K +560.0K (+100.0%) | 6.52M +6.5M (+100.0%) | 0.57% +0.567 pp | 0.37% +0.368 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 28 | THIRD POINT LLC | 556.2K +556.2K (+100.0%) | 6.48M +6.5M (+100.0%) | 0.56% +0.563 pp | 0.09% +0.089 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 29 | MORGAN STANLEY | 552.4K -148.1K (-21.1%) | 6.44M -604.1K (-8.6%) | 0.56% -0.153 pp | 0.00% +0.000 pp | USD11.65 +0.0% | 21 qtrs — |
| 30 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 550.9K +30.2K (+5.8%) | 6.42M +1.2M (+22.6%) | 0.56% +0.028 pp | 0.00% +0.000 pp | USD7.15 +62.9% | 20 qtrs — |
| 31 | NORTHERN TRUST CORP | 521.0K -10.5K (-2.0%) | 6.07M +728.2K (+13.6%) | 0.53% -0.013 pp | 0.00% +0.000 pp | USD11.74 -0.8% | 20 qtrs — |
| 32 | BANK OF AMERICA CORP /DE/ | 482.1K +210.1K (+77.2%) | 5.62M +2.9M (+105.4%) | 0.49% +0.211 pp | 0.00% +0.000 pp | USD11.15 +4.5% | 20 qtrs — |
| 33 | AMERICAN CENTURY COMPANIES INC | 455.8K +455.8K (+100.0%) | 5.31M +5.3M (+100.0%) | 0.46% +0.461 pp | 0.00% +0.003 pp | USD11.65 +0.0% | 12 qtrs — |
| 34 | ALYESKA INVESTMENT GROUP, L.P. | 418.9K +28.8K (+7.4%) | 4.88M +959.6K (+24.5%) | 0.42% +0.027 pp | 0.01% +0.002 pp | USD10.78 +8.1% | 6 qtrs — |
| 35 | JPMORGAN CHASE & CO | 417.1K +382.0K (+1,089.7%) | 4.86M +4.5M (+1,279.1%) | 0.42% +0.387 pp | 0.00% +0.000 pp | USD11.33 +2.8% | 20 qtrs — |
| 36 | FMR LLC | 399.0K -343.5K (-46.3%) | 4.65M -2.8M (-37.7%) | 0.40% -0.351 pp | 0.00% 0.000 pp | USD27.21 -57.2% | 21 qtrs — |
| 37 | LISANTI CAPITAL GROWTH, LLC | 396.5K +185.3K (+87.8%) | 4.62M +2.5M (+117.6%) | 0.40% +0.187 pp | 1.09% +0.575 pp | USD13.54 -14.0% | 4 qtrs — |
| 38 | ADAR1 CAPITAL MANAGEMENT, LLC | 369.6K +310.3K (+524.0%) | 4.31M +3.7M (+623.3%) | 0.37% +0.314 pp | 0.32% +0.260 pp | USD11.39 +2.3% | 2 qtrs — |
| 39 | EMPIRE LIFE INVESTMENTS INC. | 352.6K -3.1K (-0.9%) | 4.11M +533.2K (+14.9%) | 0.36% -0.005 pp | 0.23% +0.022 pp | USD10.05 +15.9% | 2 qtrs — |
| 40 | INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 311.5K +311.5K (+100.0%) | 3.63M +3.6M (+100.0%) | 0.32% +0.315 pp | 1.00% +1.001 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 41 | UBS ASSET MANAGEMENT AMERICAS INC | 304.4K -30.7K (-9.2%) | 3.55M +178.5K (+5.3%) | 0.31% -0.033 pp | 0.00% +0.000 pp | USD13.78 -15.5% | 10 qtrs — |
| 42 | — | 295.9K +295.9K (+100.0%) | 3.45M +3.4M (+100.0%) | 0.30% +0.299 pp | 2.40% +2.405 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 43 | EVERSEPT PARTNERS, LP | 251.6K -724.9K (-74.2%) | 2.93M -6.9M (-70.1%) | 0.25% -0.738 pp | 0.15% -0.529 pp | USD10.05 +15.9% | 2 qtrs — |
| 44 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 226.8K -33.5K (-12.9%) | 2.64M +26.2K (+1.0%) | 0.23% -0.035 pp | 0.00% +0.000 pp | USD10.90 +6.9% | 15 qtrs — |
| 45 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 216.3K +69.6K (+47.4%) | 2.52M +1.0M (+70.9%) | 0.22% +0.070 pp | 0.01% +0.005 pp | USD13.93 -16.4% | 12 qtrs — |
| 46 | ROYCE & ASSOCIATES LP | 207.1K +207.1K (+100.0%) | 2.41M +2.4M (+100.0%) | 0.21% +0.210 pp | 0.02% +0.025 pp | USD11.65 +0.0% | 12 qtrs — |
| 47 | FAS WEALTH PARTNERS, INC. | 202.4K +1.8K (+0.9%) | 2.36M +341.8K (+17.0%) | 0.20% +0.001 pp | 0.15% +0.016 pp | USD10.36 +12.5% | 11 qtrs — |
| 48 | BOOTHBAY FUND MANAGEMENT, LLC | 201.5K +201.5K (+100.0%) | 2.35M +2.3M (+100.0%) | 0.20% +0.204 pp | 0.04% +0.035 pp | USD11.65 +0.0% | 3 qtrs — |
| 49 | BARCLAYS PLC | 196.4K +84.7K (+75.9%) | 2.29M +668.8K (+41.3%) | 0.20% +0.085 pp | 0.00% +0.000 pp | USD14.20 -18.0% | 16 qtrs — |
| 50 | DAFNA CAPITAL MANAGEMENT LLC | 190.1K +49.6K (+35.3%) | 2.21M +802.2K (+56.8%) | 0.19% +0.050 pp | 0.51% +0.166 pp | USD10.47 +11.3% | 9 qtrs — |
| 51 | K2 PRINCIPAL FUND, L.P. | 181.1K +117.9K (+186.6%) | 2.11M +1.5M (+232.2%) | 0.18% +0.119 pp | 0.17% +0.118 pp | USD11.09 +5.0% | 12 qtrs — |
| 52 | DIMENSIONAL FUND ADVISORS LP | 176.1K -2.0K (-1.1%) | 2.05M +261.4K (+14.6%) | 0.18% -0.003 pp | 0.00% +0.000 pp | USD5.46 +113.4% | 15 qtrs — |
| 53 | WEXFORD CAPITAL LP | 165.3K -2.9K (-1.7%) | 1.93M +235.1K (+13.9%) | 0.17% -0.004 pp | 0.37% +0.129 pp | USD13.15 -11.4% | 6 qtrs — |
| 54 | BANK OF NEW YORK MELLON CORP | 163.0K +8.4K (+5.4%) | 1.90M +345.2K (+22.2%) | 0.17% +0.008 pp | 0.00% +0.000 pp | USD8.91 +30.8% | 13 qtrs — |
| 55 | QUINN OPPORTUNITY PARTNERS LLC | 155.0K +30.0K (+24.0%) | 1.81M +549.5K (+43.7%) | 0.16% +0.030 pp | 0.08% -0.013 pp | USD11.09 +5.0% | 4 qtrs — |
| 56 | WOODLINE PARTNERS LP | 150.9K +— (+0.0%) | 1.76M +241.5K (+15.9%) | 0.15% -0.001 pp | 0.01% 0.000 pp | USD11.87 -1.9% | 21 qtrs — |
| 57 | TREXQUANT INVESTMENT LP | 150.1K -481.6K (-76.2%) | 1.75M -4.6M (-72.5%) | 0.15% -0.490 pp | 0.02% -0.050 pp | USD10.05 +15.9% | 8 qtrs — |
| 58 | NUVEEN, LLC | 149.6K +— (+0.0%) | 1.74M +239.4K (+15.9%) | 0.15% -0.001 pp | 0.00% +0.000 pp | USD12.40 -6.0% | 4 qtrs — |
| 59 | KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | 130.7K -3.7K (-2.8%) | 1.52M +171.5K (+12.7%) | 0.13% -0.004 pp | 0.09% +0.009 pp | USD12.23 -4.7% | 4 qtrs — |
| 60 | RAFFERTY ASSET MANAGEMENT, LLC | 115.6K -6.8K (-5.6%) | 1.35M +116.1K (+9.4%) | 0.12% -0.008 pp | 0.00% +0.001 pp | USD10.31 +13.0% | 8 qtrs — |
| 61 | PRINCIPAL FINANCIAL GROUP INC | 112.8K +35.9K (+46.7%) | 1.31M +541.0K (+70.0%) | 0.11% +0.036 pp | 0.00% +0.000 pp | USD14.20 -18.0% | 3 qtrs — |
| 62 | LEGATO CAPITAL MANAGEMENT LLC | 109.1K +69.7K (+176.8%) | 1.27M +874.9K (+220.9%) | 0.11% +0.070 pp | 0.11% +0.066 pp | USD12.26 -5.0% | 6 qtrs — |
| 63 | SWISS NATIONAL BANK | 107.2K +22.9K (+27.2%) | 1.25M +401.7K (+47.4%) | 0.11% +0.023 pp | 0.00% +0.000 pp | USD9.33 +24.9% | 11 qtrs — |
| 64 | SIT INVESTMENT ASSOCIATES INC | 92.9K +18.4K (+24.6%) | 1.08M +333.0K (+44.5%) | 0.09% +0.018 pp | 0.02% +0.006 pp | USD13.58 -14.2% | 3 qtrs — |
| 65 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 87.2K +— (+0.0%) | 1.02M +139.0K (+15.9%) | 0.09% 0.000 pp | 0.00% +0.000 pp | USD14.50 -19.7% | 6 qtrs — |
| 66 | VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 83.2K +— (+0.0%) | 969.6K +133.2K (+15.9%) | 0.08% 0.000 pp | 0.28% +0.037 pp | USD14.50 -19.7% | 6 qtrs — |
| 67 | ALPS ADVISORS INC | 81.2K +31.6K (+63.6%) | 945.6K +447.1K (+89.7%) | 0.08% +0.032 pp | 0.01% +0.003 pp | USD15.19 -23.3% | 3 qtrs — |
| 68 | MARSHALL WACE, LLP | 79.2K -118.1K (-59.9%) | 922.8K -1.1M (-53.5%) | 0.08% -0.120 pp | 0.00% -0.001 pp | USD10.69 +9.0% | 6 qtrs — |
| 69 | SG AMERICAS SECURITIES, LLC | 76.2K +66.1K (+654.1%) | 888.0K +786.0K (+770.6%) | 0.08% +0.067 pp | 0.00% +0.001 pp | USD11.27 +3.4% | 8 qtrs — |
| 70 | ASSUREDPARTNERS INVESTMENT ADVISORS, LLC | 75.8K +18.0K (+31.1%) | 882.8K +302.1K (+52.0%) | 0.08% +0.018 pp | 0.13% +0.002 pp | USD11.68 -0.3% | 5 qtrs — |
| 71 | SEI INVESTMENTS CO | 74.8K +26.7K (+55.5%) | 871.5K +388.0K (+80.2%) | 0.08% +0.027 pp | 0.00% +0.000 pp | USD10.94 +6.5% | 5 qtrs — |
| 72 | WELLS FARGO & COMPANY/MN | 74.3K +414.0 (+0.6%) | 865.1K +123.0K (+16.6%) | 0.08% +0.000 pp | 0.00% +0.000 pp | USD11.17 +4.3% | 20 qtrs — |
| 73 | RHUMBLINE ADVISERS | 73.3K -7.9K (-9.7%) | 853.9K +37.8K (+4.6%) | 0.07% -0.008 pp | 0.00% +0.000 pp | USD9.29 +25.4% | 11 qtrs — |
| 74 | HRT FINANCIAL LP | 68.6K +68.6K (+100.0%) | 799.0K +799.0K (+100.0%) | 0.07% +0.070 pp | 0.00% +0.003 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 75 | ALLIANCEBERNSTEIN L.P. | 60.1K -2.6M (-97.7%) | 700.4K -25.9M (-97.4%) | 0.06% -2.625 pp | 0.00% -0.008 pp | USD10.48 +11.2% | 11 qtrs — |
| 76 | LEGAL & GENERAL GROUP PLC | 58.4K +3.1K (+5.7%) | 680.0K +124.8K (+22.5%) | 0.06% +0.003 pp | 0.00% +0.000 pp | USD10.93 +6.6% | 12 qtrs — |
| 77 | MATISSE CAPITAL | 55.6K -2.2K (-3.9%) | 647.3K +66.5K (+11.4%) | 0.06% -0.003 pp | 0.29% +0.027 pp | USD12.62 -7.7% | 4 qtrs — |
| 78 | AMERICAN ASSETS INC | 55.0K +— (+0.0%) | 640.8K +88.0K (+15.9%) | 0.06% 0.000 pp | 0.20% +0.026 pp | USD10.05 +15.9% | 2 qtrs — |
| 79 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 54.1K +9.7K (+21.9%) | 630.2K +184.1K (+41.3%) | 0.05% +0.010 pp | 0.00% +0.000 pp | USD8.55 +36.3% | 11 qtrs — |
| 80 | COASTAL BRIDGE ADVISORS, LLC | 53.8K -37.8K (-41.3%) | 627.1K -294.2K (-31.9%) | 0.05% -0.039 pp | 0.05% -0.023 pp | USD14.59 -20.2% | 4 qtrs — |
| 81 | QUANTINNO CAPITAL MANAGEMENT LP | 53.1K +12.6K (+31.2%) | 618.8K +212.0K (+52.1%) | 0.05% +0.013 pp | 0.00% +0.000 pp | USD10.43 +11.7% | 2 qtrs — |
| 82 | PERMANENT CAPITAL MANAGEMENT, LP | 52.3K -1.0K (-1.9%) | 609.4K +73.3K (+13.7%) | 0.05% -0.001 pp | 0.12% +0.019 pp | USD10.05 +15.9% | 2 qtrs — |
| 83 | SCHULHOFF & CO INC | 51.2K +7.7K (+17.6%) | 595.9K +158.7K (+36.3%) | 0.05% +0.008 pp | 0.25% +0.064 pp | USD12.73 -8.5% | 4 qtrs — |
| 84 | DEUTSCHE BANK AG\ | 48.7K +6.8K (+16.2%) | 567.7K +146.1K (+34.6%) | 0.05% +0.007 pp | 0.00% +0.000 pp | USD9.70 +20.1% | 9 qtrs — |
| 85 | LOS ANGELES CAPITAL MANAGEMENT LLC | 65.7K +65.7K (+100.0%) | 566.7K +566.7K (+100.0%) | 0.07% +0.067 pp | 0.00% +0.002 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 86 | PROFUND ADVISORS LLC | 42.8K +16.5K (+62.6%) | 498.7K +234.1K (+88.5%) | 0.04% +0.017 pp | 0.02% +0.007 pp | USD10.84 +7.5% | 8 qtrs — |
| 87 | FOX RUN MANAGEMENT, L.L.C. | 38.6K +38.6K (+100.0%) | 449.5K +449.5K (+100.0%) | 0.04% +0.039 pp | 0.07% +0.069 pp | USD11.65 +0.0% | 1 qtrs NEW |
| 88 | INVESCO LTD. | 37.2K -2.9K (-7.2%) | 433.7K +30.6K (+7.6%) | 0.04% -0.003 pp | 0.00% +0.000 pp | USD15.67 -25.7% | 13 qtrs — |
| 89 | XTX TOPCO LTD | 37.2K -106.4K (-74.1%) | 433.4K -1.0M (-70.0%) | 0.04% -0.108 pp | 0.01% -0.064 pp | USD10.36 +12.5% | 6 qtrs — |
| 90 | AQUATIC CAPITAL MANAGEMENT LLC | 36.0K -69.7K (-65.9%) | 419.8K -643.0K (-60.5%) | 0.04% -0.071 pp | 0.01% -0.008 pp | USD13.46 -13.4% | 3 qtrs — |
| 91 | METLIFE INVESTMENT MANAGEMENT, LLC | 34.3K +— (+0.0%) | 400.0K +54.9K (+15.9%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD8.27 +40.9% | 11 qtrs — |
| 92 | VOYA INVESTMENT MANAGEMENT LLC | 34.1K -80.7K (-70.3%) | 397.6K -756.7K (-65.6%) | 0.03% -0.082 pp | 0.00% -0.001 pp | USD15.25 -23.6% | 7 qtrs — |
| 93 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 34.1K +438.0 (+1.3%) | 397.2K +61.0K (+18.1%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD11.54 +1.0% | 7 qtrs — |
| 94 | PRICE T ROWE ASSOCIATES INC /MD/ | 33.8K +— (+0.0%) | 394.0K +54.0K (+15.9%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD13.93 -16.4% | 7 qtrs — |
| 95 | DIKER MANAGEMENT LLC | 33.5K -10.0K (-23.0%) | 390.4K -46.9K (-10.7%) | 0.03% -0.010 pp | 0.30% -0.051 pp | USD14.67 -20.6% | 4 qtrs — |
| 96 | QUEST PARTNERS LLC | 33.0K -12.8K (-28.0%) | 384.1K -76.4K (-16.6%) | 0.03% -0.013 pp | 0.02% -0.009 pp | USD11.84 -1.6% | 5 qtrs — |
| 97 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 32.1K -415.0 (-1.3%) | 373.5K +47.1K (+14.4%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD12.54 -7.1% | 7 qtrs — |
| 98 | PRIVATE ADVISOR GROUP, LLC | 31.5K +10.9K (+52.9%) | 366.5K +159.7K (+77.2%) | 0.03% +0.011 pp | 0.00% +0.001 pp | USD10.60 +9.9% | 2 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 79 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Global X - S&P Biotech ETF CURE.AX | 0.17% | 60.6K | 0.45% |
| 2 | State Street SPDR S&P Biotech ETF XBI | 0.17% | 18.21M | 0.35% |
| 3 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.05% | 251.1K | 0.40% |
| 4 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.05% | 40.5K | 0.19% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.05% | 584.6K | 0.35% |
| 6 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.05% | 39.1K | 0.35% |
| 7 | iShares U.S. Small-Cap Equity Factor ETF SMLF | 0.04% | 1.63M | 0.15% |
| 8 | iShares Biotechnology ETF IBB | 0.04% | 3.58M | 0.44% |
| 9 | Pacer WealthShield ETF PWS | 0.03% | 8.4K | 0.60% |
| 10 | ProShares Ultra Nasdaq Biotechnology BIB | 0.03% | 26.4K | 1.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.29
Bearish
Ratio by volume
0.09
Bearish
Buys
2
Sells
7
Shares acquired
51.8K
Shares disposed
590.0K
Cash buys
—
Cash sales
3.00
Net activity
-538,208
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | Tanimoto Sarina | Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 875,000 | 11.49 | 10.05M | 875,000 | I | ↗ |
| 2026-01-02 | Scott Kathleen D. | Officer | A-Award | A | Stock option (right to buy) | 240,000 | 11.49 | 2.76M | 240,000 | D | ↗ |
| 2026-01-02 | Lowenthal Richard E | Director / Officer / 10% Owner | A-Award | A | Stock option (right to buy) | 875,000 | 11.49 | 10.05M | 875,000 | D | ↗ |
| 2026-01-02 | Karas Eric | Officer | A-Award | A | Stock option (right to buy) | 240,000 | 11.49 | 2.76M | 240,000 | D | ↗ |
| 2026-01-02 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 240,000 | 11.49 | 2.76M | 240,000 | D | ↗ |
| 2026-01-02 | Dorsey Brian | Officer | A-Award | A | Stock option (right to buy) | 240,000 | 11.49 | 2.76M | 240,000 | D | ↗ |
| 2026-01-02 | Chakma Justin | Officer | A-Award | A | Stock option (right to buy) | 240,000 | 11.49 | 2.76M | 240,000 | D | ↗ |
| 2025-11-13 | Dorsey Brian | Officer | M-Exempt | A | Common Stock | 21,828 | 0.64 | 14.0K | 32,617 | D | ↗ |
| 2025-11-12 | Shah Pratik | Director | G-Gift | D | Common Stock | 100,000 | 0.00 | — | 4,474,554 | I | ↗ |
| 2025-11-12 | Chakma Justin | Officer | S-Sale | D | Common Stock | 136,380 | 8.86 | 1.21M | 0 | D | ↗ |
| 2025-08-21 | Scott Kathleen D. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 1.50 | 18.8K | 739,830 | D | ↗ |
| 2025-08-21 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 14.49 | 724.3K | 1,196,494 | I | ↗ |
| 2025-08-20 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 37,656 | 14.09 | 530.6K | 1,247,447 | I | ↗ |
| 2025-08-19 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 12,344 | 14.03 | 173.1K | 1,285,103 | I | ↗ |
| 2025-07-01 | Karas Eric | Officer | S-Sale | D | Common Stock | 15,000 | 16.99 | 254.9K | 10,315 | D | ↗ |
| 2025-06-27 | Flynn James E | 10% Owner | S-Sale | D | Class A Common Stock | 370,074 | 18.46 | 6.83M | 4,887,254 | I | ↗ |
| 2025-06-25 | Thompson Peter A. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | Shawver Laura | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | Shah Pratik | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | SCHNEIDER PHILLIP M | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | SAUNDERS BRENT L | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 30,000 | 17.26 | 517.8K | 30,000 | I | ↗ |
| 2025-06-25 | Kelly Michael | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | Islam Saqib | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-25 | Dadoo Rajeev | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 17.26 | 517.8K | 30,000 | D | ↗ |
| 2025-06-18 | Karas Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 15,000 | 1.50 | 22.5K | 559,588 | D | ↗ |
| 2025-05-20 | Scott Kathleen D. | Officer | M-Exempt | A | Common Stock | 50,000 | 1.50 | 75.0K | 57,424 | D | ↗ |
| 2025-05-20 | SAUNDERS BRENT L | Director | S-Sale | D | Common Stock | 120,000 | 14.25 | 1.71M | 0 | D | ↗ |
| 2025-05-20 | Fitzpatrick Alexander A | Officer | M-Exempt | A | Common Stock | 100,000 | 5.58 | 558.0K | 192,582 | D | ↗ |
| 2025-04-07 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 27,493 | 4.85 | 133.3K | 24,062 | D | ↗ |
| 2025-03-20 | Karas Eric | Officer | M-Exempt | A | Common Stock | 10,000 | 1.50 | 15.0K | 17,696 | D | ↗ |
| 2025-03-06 | Shawver Laura | Director | M-Exempt | A | Common Stock | 49,600 | 4.85 | 240.6K | 259,946 | D | ↗ |
| 2025-03-05 | Shawver Laura | Director | M-Exempt | A | Common Stock | 400 | 4.85 | 1.9K | 210,746 | D | ↗ |
| 2025-02-03 | Shawver Laura | Director | M-Exempt | A | Common Stock | 40,936 | 4.85 | 198.5K | 260,346 | D | ↗ |
| 2025-01-06 | Shawver Laura | Director | S-Sale | D | Common Stock | 50,000 | 11.10 | 555.1K | 210,346 | D | ↗ |
| 2025-01-02 | Tanimoto Sarina | Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 767,600 | 10.71 | 8.22M | 767,600 | I | ↗ |
| 2025-01-02 | Scott Kathleen D. | Officer | A-Award | A | Stock option (right to buy) | 176,700 | 10.71 | 1.89M | 176,700 | D | ↗ |
| 2025-01-02 | Lowenthal Richard E | Director / Officer / 10% Owner | A-Award | A | Stock option (right to buy) | 767,600 | 10.71 | 8.22M | 767,600 | D | ↗ |
| 2025-01-02 | Karas Eric | Officer | A-Award | A | Stock option (right to buy) | 152,300 | 10.71 | 1.63M | 152,300 | D | ↗ |
| 2025-01-02 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 152,300 | 10.71 | 1.63M | 152,300 | D | ↗ |
| 2025-01-02 | Dorsey Brian | Officer | A-Award | A | Stock option (right to buy) | 261,900 | 10.71 | 2.80M | 261,900 | D | ↗ |
| 2025-01-02 | Chakma Justin | Officer | A-Award | A | Stock option (right to buy) | 274,100 | 10.71 | 2.94M | 274,100 | D | ↗ |
| 2024-12-17 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 11.67 | 583.6K | 1,297,447 | I | ↗ |
| 2024-12-17 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 11.67 | 583.6K | 1,297,447 | I | ↗ |
| 2024-12-13 | Chakma Justin | Officer | M-Exempt | A | Common Stock | 27,272 | 1.44 | 39.3K | 163,652 | D | ↗ |
| 2024-12-12 | Dorsey Brian | Officer | S-Sale | D | Common Stock | 25,000 | 12.30 | 307.4K | 6,024 | D | ↗ |
| 2024-12-12 | Chakma Justin | Officer | M-Exempt | A | Common Stock | 117,333 | 0.84 | 98.6K | 253,713 | D | ↗ |
| 2024-12-11 | Dorsey Brian | Officer | S-Sale | D | Common Stock | 15,000 | 12.43 | 186.4K | 6,024 | D | ↗ |
| 2024-12-10 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 13.17 | 658.3K | 1,246,494 | I | ↗ |
| 2024-12-10 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 13.17 | 658.3K | 1,246,494 | I | ↗ |
| 2024-12-10 | Chakma Justin | Officer | M-Exempt | A | Common Stock | 50,000 | 0.84 | 42.0K | 186,380 | D | ↗ |
| 2024-12-06 | Tanimoto Sarina | Officer / 10% Owner | M-Exempt | A | Common Stock | 11,876 | 8.42 | 100.0K | 3,433,512 | D | ↗ |
| 2024-12-06 | Lowenthal Richard E | Director / Officer / 10% Owner | M-Exempt | D | Stock Option (right to buy) | 13,789 | 1.44 | 19.9K | 20,684 | I | ↗ |
| 2024-12-06 | Chakma Justin | Officer | M-Exempt | A | Common Stock | 50,000 | 0.84 | 42.0K | 186,380 | D | ↗ |
| 2024-12-05 | Chakma Justin | Officer | M-Exempt | A | Common Stock | 49,640 | 0.84 | 41.7K | 186,020 | D | ↗ |
| 2024-12-04 | Shawver Laura | Director | M-Exempt | A | Common Stock | 14,772 | 3.15 | 46.5K | 225,118 | D | ↗ |
| 2024-12-04 | Karas Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 6,283 | 1.50 | 9.4K | 584,588 | D | ↗ |
| 2024-12-04 | Chakma Justin | Officer | S-Sale | D | Common Stock | 45,000 | 13.95 | 627.9K | 136,380 | D | ↗ |
| 2024-12-03 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 62,378 | 3.15 | 196.5K | 73,836 | D | ↗ |
| 2024-12-03 | Chakma Justin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,260 | 0.84 | 2.7K | 0 | D | ↗ |
| 2024-12-02 | Shawver Laura | Director | S-Sale | D | Common Stock | 96,343 | 13.55 | 1.31M | 211,247 | D | ↗ |
| 2024-12-02 | Karas Eric | Officer | M-Exempt | A | Common Stock | 3,717 | 1.50 | 5.6K | 9,410 | D | ↗ |
| 2024-12-02 | Chakma Justin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 45,000 | 0.84 | 37.8K | 3,260 | D | ↗ |
| 2024-11-27 | Chakma Justin | Officer | S-Sale | D | Common Stock | 25,000 | 14.39 | 359.8K | 136,380 | D | ↗ |
| 2024-11-26 | Chakma Justin | Officer | S-Sale | D | Common Stock | 42,186 | 14.05 | 592.6K | 161,380 | D | ↗ |
| 2024-11-25 | Chakma Justin | Officer | S-Sale | D | Common Stock | 32,814 | 14.00 | 459.4K | 203,566 | D | ↗ |
| 2024-11-19 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 13.95 | 697.5K | 1,347,447 | I | ↗ |
| 2024-11-19 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 13.95 | 697.5K | 1,347,447 | I | ↗ |
| 2024-11-12 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 4,876 | 17.64 | 86.0K | 1,248,499 | I | ↗ |
| 2024-11-12 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,876 | 17.64 | 86.0K | 1,248,499 | I | ↗ |
| 2024-11-12 | Flynn James E | 10% Owner | S-Sale | D | Class A Common Stock | 9,554 | 17.77 | 169.8K | 5,257,329 | I | ↗ |
| 2024-11-11 | Flynn James E | 10% Owner | S-Sale | D | Class A Common Stock | 40,596 | 17.45 | 708.4K | 5,498,368 | I | ↗ |
| 2024-10-16 | Scott Kathleen D. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 1.50 | 18.8K | 802,330 | D | ↗ |
| 2024-10-15 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 14.88 | 743.8K | 1,298,499 | I | ↗ |
| 2024-10-15 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 14.88 | 743.8K | 1,298,499 | I | ↗ |
| 2024-10-08 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 13.83 | 691.4K | 1,348,499 | I | ↗ |
| 2024-10-08 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 13.83 | 691.4K | 1,348,499 | I | ↗ |
| 2024-09-18 | Karas Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 1.50 | 15.0K | 594,588 | — | ↗ |
| 2024-09-17 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 12.93 | 646.7K | 1,398,499 | — | ↗ |
| 2024-09-17 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 12.93 | 646.7K | 1,398,499 | — | ↗ |
| 2024-09-10 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 11.50 | 574.9K | 1,448,499 | — | ↗ |
| 2024-09-10 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 11.50 | 574.9K | 1,448,499 | — | ↗ |
| 2024-08-26 | Thompson Peter A. | Director | S-Sale | D | Common Stock | 83,695 | 13.00 | 1.09M | 0 | — | ↗ |
| 2024-08-26 | ORBIMED ADVISORS LLC | Director | S-Sale | D | Common Stock | 83,695 | 13.00 | 1.09M | 0 | — | ↗ |
| 2024-08-23 | Thompson Peter A. | Director | S-Sale | D | Common Stock | 69,500 | 13.03 | 905.6K | 83,695 | — | ↗ |
| 2024-08-23 | ORBIMED ADVISORS LLC | Director | S-Sale | D | Common Stock | 69,500 | 13.03 | 905.6K | 83,695 | — | ↗ |
| 2024-08-22 | Thompson Peter A. | Director | S-Sale | D | Common Stock | 391,482 | 12.94 | 5.07M | 153,195 | — | ↗ |
| 2024-08-22 | ORBIMED ADVISORS LLC | Director | S-Sale | D | Common Stock | 391,482 | 12.94 | 5.07M | 153,195 | — | ↗ |
| 2024-08-21 | Thompson Peter A. | Director | S-Sale | D | Common Stock | 13,300 | 14.61 | 194.3K | 544,677 | — | ↗ |
| 2024-08-21 | ORBIMED ADVISORS LLC | Director | S-Sale | D | Common Stock | 394,400 | 13.52 | 5.33M | 557,977 | — | ↗ |
| 2024-08-20 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 36,216 | 14.76 | 534.5K | 1,512,283 | — | ↗ |
| 2024-08-20 | Scott Kathleen D. | Officer | S-Sale | D | Common Stock | 12,500 | 16.00 | 200.0K | 13,199 | — | ↗ |
| 2024-08-20 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 11,523 | 15.62 | 180.0K | 1,500,760 | — | ↗ |
| 2024-08-20 | Dorsey Brian | Officer | S-Sale | D | Common Stock | 50,000 | 15.00 | 750.0K | 6,024 | — | ↗ |
| 2024-08-19 | Karas Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 1.50 | 15.0K | 604,588 | — | ↗ |
| 2024-08-13 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 35,401 | 12.76 | 451.9K | 1,446,494 | — | ↗ |
| 2024-08-13 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 35,401 | 12.76 | 451.9K | 1,446,494 | — | ↗ |
| 2024-08-13 | Dorsey Brian | Officer | S-Sale | D | Common Stock | 30,000 | 13.00 | 390.0K | 6,024 | — | ↗ |
| 2024-07-16 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 11.40 | 570.1K | 1,547,447 | — | ↗ |
| 2024-07-16 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 11.40 | 570.1K | 1,547,447 | — | ↗ |
| 2024-07-09 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.62 | 480.8K | 1,648,499 | — | ↗ |
| 2024-07-09 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.62 | 480.8K | 1,648,499 | — | ↗ |
| 2024-06-20 | Thompson Peter A. | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | Shawver Laura | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | Shah Pratik | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | SCHNEIDER PHILLIP M | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | SAUNDERS BRENT L | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | Kelly Michael | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | Islam Saqib | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-20 | Dadoo Rajeev | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 7.73 | 309.2K | 40,000 | — | ↗ |
| 2024-06-13 | Shah Pratik | Director | G-Gift | D | Common Stock | 200,000 | 0.00 | — | 1,132,900 | — | ↗ |
| 2024-06-12 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 47,834 | 9.15 | 437.5K | 1,546,494 | — | ↗ |
| 2024-06-12 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 47,834 | 9.15 | 437.5K | 1,546,494 | — | ↗ |
| 2024-06-11 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 1,972 | 9.00 | 17.8K | 1,746,527 | — | ↗ |
| 2024-06-11 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,166 | 9.00 | 19.5K | 1,594,328 | — | ↗ |
| 2024-06-07 | Shah Pratik | Director / 10% Owner | G-Gift | D | Common Stock | 1,332,950 | 0.00 | — | 4,824,554 | — | ↗ |
| 2024-06-04 | Shah Pratik | Director / 10% Owner | J-Other | D | Common Stock | 2,665,800 | 0.00 | — | 7,490,404 | — | ↗ |
| 2024-05-16 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 44,746 | 9.06 | 405.3K | 1,597,447 | — | ↗ |
| 2024-05-16 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 44,746 | 9.06 | 405.3K | 1,597,447 | — | ↗ |
| 2024-05-15 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 2,381 | 9.05 | 21.6K | 1,642,193 | — | ↗ |
| 2024-05-15 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,381 | 9.05 | 21.6K | 1,642,193 | — | ↗ |
| 2024-05-14 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 2,884 | 9.01 | 26.0K | 1,795,615 | — | ↗ |
| 2024-05-14 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,873 | 9.01 | 25.9K | 1,644,574 | — | ↗ |
| 2024-05-07 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.34 | 467.2K | 1,798,499 | — | ↗ |
| 2024-05-07 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.34 | 467.2K | 1,798,499 | — | ↗ |
| 2024-04-23 | Tanimoto Sarina | Officer / 10% Owner | M-Exempt | D | Stock Option (right to buy) | 48,260 | 1.44 | 69.5K | 34,473 | — | ↗ |
| 2024-04-23 | Lowenthal Richard E | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 48,260 | 1.44 | 69.5K | 3,407,847 | — | ↗ |
| 2024-04-19 | Tanimoto Sarina | Officer / 10% Owner | M-Exempt | A | Common Stock | 69,444 | 1.44 | 100.0K | 4,315,313 | — | ↗ |
| 2024-04-19 | Lowenthal Richard E | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 69,444 | 1.44 | 100.0K | 4,315,313 | — | ↗ |
| 2024-04-16 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.28 | 464.0K | 1,647,447 | — | ↗ |
| 2024-04-16 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.28 | 464.0K | 1,647,447 | — | ↗ |
| 2024-04-09 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.28 | 463.9K | 1,898,499 | — | ↗ |
| 2024-04-09 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 9.28 | 463.9K | 1,898,499 | — | ↗ |
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 505,954 | 9.79 | 4.95M | 9,958,073 | — | ↗ |
| 2024-03-26 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 457,745 | 9.55 | 4.37M | 9,452,119 | — | ↗ |
| 2024-03-25 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 47,635 | 9.12 | 434.6K | 1,697,447 | — | ↗ |
| 2024-03-25 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 437,600 | 9.06 | 3.96M | 8,994,374 | — | ↗ |
| 2024-03-25 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 47,632 | 9.12 | 434.6K | 1,948,499 | — | ↗ |
| 2024-03-22 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 1,326 | 9.01 | 12.0K | 1,996,131 | — | ↗ |
| 2024-03-22 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,017 | 9.03 | 9.2K | 1,745,082 | — | ↗ |
| 2024-03-21 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 9.00 | 900.00 | 1,997,457 | — | ↗ |
| 2024-03-21 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 9.00 | 900.00 | 1,997,457 | — | ↗ |
| 2024-03-19 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 942 | 9.04 | 8.5K | 1,997,557 | — | ↗ |
| 2024-03-19 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 942 | 9.04 | 8.5K | 1,997,557 | — | ↗ |
| 2024-03-15 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 48,295 | 9.14 | 441.5K | 1,696,494 | — | ↗ |
| 2024-03-15 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 48,295 | 9.14 | 441.5K | 1,696,494 | — | ↗ |
| 2024-03-14 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 205 | 9.00 | 1.8K | 1,744,789 | — | ↗ |
| 2024-03-14 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 205 | 9.00 | 1.8K | 1,744,789 | — | ↗ |
| 2024-03-13 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 1,300 | 9.00 | 11.7K | 2,047,199 | — | ↗ |
| 2024-03-13 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,500 | 9.00 | 13.5K | 1,744,994 | — | ↗ |
| 2024-02-29 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 1,982 | 9.01 | 17.9K | 2,048,499 | — | ↗ |
| 2024-02-29 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,982 | 9.01 | 17.9K | 2,048,499 | — | ↗ |
| 2024-02-28 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 24,303 | 9.02 | 219.2K | 1,748,447 | — | ↗ |
| 2024-02-28 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,456 | 9.02 | 229.6K | 1,747,294 | — | ↗ |
| 2024-02-26 | Tanimoto Sarina | Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 9.01 | 901.00 | 1,772,750 | — | ↗ |
| 2024-02-26 | Lowenthal Richard E | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 9.01 | 901.00 | 1,772,750 | — | ↗ |
| 2024-01-02 | Tanimoto Sarina | Officer / 10% Owner | A-Award | A | Stock option (right to buy) | 300,000 | 5.58 | 1.67M | 300,000 | — | ↗ |
| 2024-01-02 | Scott Kathleen D. | Officer | A-Award | A | Stock option (right to buy) | 200,000 | 5.58 | 1.12M | 200,000 | — | ↗ |
| 2024-01-02 | Lowenthal Richard E | Director / Officer / 10% Owner | A-Award | A | Stock option (right to buy) | 300,000 | 5.58 | 1.67M | 300,000 | — | ↗ |
| 2024-01-02 | Karas Eric | Officer | A-Award | A | Stock option (right to buy) | 200,000 | 5.58 | 1.12M | 200,000 | — | ↗ |
| 2024-01-02 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 300,000 | 5.58 | 1.67M | 300,000 | — | ↗ |
| 2024-01-02 | Dorsey Brian | Officer | A-Award | A | Stock option (right to buy) | 350,000 | 5.58 | 1.95M | 350,000 | — | ↗ |
| 2024-01-02 | Chakma Justin | Officer | A-Award | A | Stock option (right to buy) | 350,000 | 5.58 | 1.95M | 350,000 | — | ↗ |
| 2023-09-29 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 46,258 | 3.78 | 175.0K | 89,227 | — | ↗ |
| 2023-09-28 | Fitzpatrick Alexander A | Officer | P-Purchase | A | Common Stock | 40,000 | 3.62 | 145.0K | 42,969 | — | ↗ |
| 2023-09-21 | RA CAPITAL MANAGEMENT, L.P. | Director | P-Purchase | A | Common Stock | 2,508,691 | 2.97 | 7.45M | 8,365,465 | — | ↗ |
| 2023-09-01 | Shawver Laura | Director | M-Exempt | A | Common Stock | 97,003 | 1.27 | 123.2K | 310,346 | — | ↗ |
| 2023-08-29 | Thompson Peter A. | Director | P-Purchase | A | Common Stock | 500,000 | 6.20 | 3.10M | 8,019,187 | — | ↗ |
| 2023-08-29 | RA CAPITAL MANAGEMENT, L.P. | Director | P-Purchase | A | Common Stock | 3,750,000 | 6.20 | 23.25M | 5,856,774 | — | ↗ |
| 2023-08-29 | ORBIMED ADVISORS LLC | Director | P-Purchase | A | Common Stock | 500,000 | 6.20 | 3.10M | 8,019,187 | — | ↗ |
| 2023-08-04 | Shawver Laura | Director | M-Exempt | A | Common Stock | 18,897 | 1.27 | 24.0K | 229,243 | — | ↗ |
| 2023-08-03 | Shawver Laura | Director | M-Exempt | A | Common Stock | 26,107 | 1.27 | 33.2K | 236,453 | — | ↗ |
| 2023-08-02 | Shawver Laura | Director | M-Exempt | A | Common Stock | 36,281 | 1.27 | 46.1K | 246,627 | — | ↗ |
| 2023-08-01 | Shawver Laura | Director | S-Sale | D | Common Stock | 18,715 | 7.19 | 134.6K | 210,346 | — | ↗ |
| 2023-07-07 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 8,858 | 1.27 | 11.2K | 102,997 | — | ↗ |
| 2023-07-06 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 33,510 | 1.27 | 42.6K | 111,855 | — | ↗ |
| 2023-07-05 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 31,112 | 1.27 | 39.5K | 145,365 | — | ↗ |
| 2023-07-03 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 26,520 | 1.27 | 33.7K | 176,477 | — | ↗ |
| 2023-06-27 | Thompson Peter A. | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | Shawver Laura | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | Shah Pratik | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | SCHNEIDER PHILLIP M | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | SAUNDERS BRENT L | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | RA CAPITAL MANAGEMENT, L.P. | Director | A-Award | A | Stock Option (Right to Buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | Kelly Michael | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | Islam Saqib | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-27 | Dadoo Rajeev | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.50 | 260.0K | 40,000 | — | ↗ |
| 2023-06-02 | Shawver Laura | Director | M-Exempt | A | Common Stock | 26,941 | 1.27 | 34.2K | 237,287 | — | ↗ |
| 2023-06-01 | Shawver Laura | Director | M-Exempt | A | Common Stock | 73,059 | 1.27 | 92.8K | 283,405 | — | ↗ |
| 2023-05-17 | Tanimoto Sarina | Officer / 10% Owner | G-Gift | A | Common Stock | 1,050,000 | 0.00 | — | 1,050,000 | — | ↗ |
| 2023-05-17 | Lowenthal Richard E | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 1,050,000 | 0.00 | — | 4,126,822 | — | ↗ |
| 2023-05-09 | Shawver Laura | Director | M-Exempt | D | Stock Option (Right to Buy) | 42,900 | 1.27 | 54.5K | 302,997 | — | ↗ |
| 2023-05-08 | Shawver Laura | Director | M-Exempt | A | Common Stock | 57,100 | 1.27 | 72.5K | 267,446 | — | ↗ |
| 2023-01-03 | Tanimoto Sarina | Officer | A-Award | A | Stock option (right to buy) | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2023-01-03 | Scott Kathleen D. | Officer | A-Award | A | Stock option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2023-01-03 | Lowenthal Richard E | Officer | A-Award | A | Stock option (right to buy) | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2023-01-03 | Karas Eric | Officer | A-Award | A | Stock option (right to buy) | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2023-01-03 | Fitzpatrick Alexander A | Officer | A-Award | A | Stock option (right to buy) | 700,000 | 0.00 | — | 700,000 | — | ↗ |
| 2023-01-03 | Dorsey Brian | Officer | A-Award | A | Stock option (right to buy) | 145,000 | 0.00 | — | 145,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-11.6K
Shares Outstanding
99.30M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Richard Lowenthal, M.S., MSEL President and Chief Executive Officer | 700.0K | — | — | 6.18M | 315.0K | 2.47M | 9.66M | 63.96% | ↗ |
| 2 | 2025 | Sarina Tanimoto, M.D., M.B.A. Chief Medical Officer | 540.0K | — | — | 2.11M | 178.2K | 2.47M | 5.29M | 39.83% | ↗ |
| 3 | 2025 | Justin Chakma Chief Business Officer | 497.0K | — | — | 2.21M | 164.0K | 21.7K | 2.89M | 76.36% | ↗ |
| 4 | 2024 | Richard Lowenthal, M.S., MSEL President and Chief Executive Officer | 651.0K | — | — | 3.84M | 507.8K | 2.17M | 7.17M | 53.55% | ↗ |
| 5 | 2024 | Sarina Tanimoto, M.D., M.B.A. Chief Medical Officer | 501.7K | — | — | 1.31M | 260.9K | 2.17M | 4.25M | 30.84% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard Lowenthal MSMSEL | Co-Founder, President, Chief Executive Officer & Director | 3M | male |
| Sarina Tanimoto | Co-Founder & Chief Medical Officer | 3M | — |
| Brian T. Dorsey | Chief Operations Officer | 707.0K | male |
| Justin Chakma | Chief Business Officer | 682.7K | male |
| Alexander A. Fitzpatrick | Chief Legal Officer & Secretary | 677.1K | male |
| Eric Karas | Chief Commercial Officer | 618.6K | male |
| Kathleen D. Scott | Chief Financial Officer | — | female |
| Lynda Harris | Vice President of Human Resources | — | female |
| Robert Bell | Co-Founder & Chief Science Officer | — | — |
| Daniel Relovsky | Senior Vice President of Marketing | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SPRY
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
